SEGMENT INFORMATION: (Tables)

3 Months Ended

Mar. 31, 2013

SEGMENT INFORMATION:

Summary of financial information for each of the reportable segments

	Three months ended
	March 31,
($ in millions)	2013		2012
Net Sales:
Lithium	$	118.5	$	114.7
Surface Treatment	184.5		188.6
Performance Additives	177.1		196.5
Titanium Dioxide Pigments	273.1		225.1
Advanced Ceramics	142.9		144.6
Corporate and other	38.5		40.0
Total	$	934.6	$	909.5

Schedule of identifiable assets

	Three months ended
	March 31,
($ in millions)	2013			2012
Adjusted EBITDA
Lithium	$	46.9		$	44.4
Surface Treatment	39.5			39.7
Performance Additives	35.8			38.8
Titanium Dioxide Pigments	8.6			75.6
Advanced Ceramics	46.5			46.3
Corporate and other	(9.1		)	(9.9		)
Total	$	168.2		$	234.9

	Identifiable Assets as of
	March 31,			December 31,
($ in millions)	2013			2012
Lithium	$	1,278.8		$	1,282.0
Surface Treatment	995.5			982.4
Performance Additives	694.1			675.8
Titanium Dioxide Pigments	1,074.2			1,130.0
Advanced Ceramics	805.3			813.2
Corporate and other (a)	780.4			1,550.8
Eliminations (b)	(458.2		)	(460.5		)
Total	$	5,170.1		$	5,973.7

(a) Corporate and other identifiable assets primarily represent the operating assets of the businesses included herein described above, assets (primarily real estate) of legacy businesses formerly belonging to the Dynamit Nobel businesses acquired in 2004, deferred income tax assets and cash and cash equivalent balances maintained in accordance with centralized cash management techniques.

(b) Amounts included in “Eliminations” represent individual subsidiaries’ retained interest in their cumulative net cash balance (deposits less withdrawals) included in the corporate cash concentration arrangements. These amounts are eliminated as the cash concentration arrangement balances are included in the Corporate and other segment’s identifiable assets.

Schedule of calculation of EBITDA

								Titanium
			Surface			Performance		Dioxide			Advanced			Corporate
($ in millions)	Lithium		Treatment			Additives		Pigments			Ceramics			and other			Consolidated
Three months ended March 31, 2013
Income (loss) before taxes	$	30.4	$	27.2		$	19.1	$	(33.3	)	$	29.4		$	(47.9	)	$	24.9
Interest expense, net	0.7		3.0			1.4		5.9			3.6			14.4			29.0
Depreciation and amortization	11.1		7.9			14.4		18.2			13.1			2.3			67.0
Restructuring and other severance costs (a)	3.9		2.2			0.6		0.3			0.1			—			7.1
Systems/organization establishment expenses (income) (b)	0.1		0.6			—		(0.1		)	—			—			0.6
Acquisition and disposal costs (c)	0.1		—			0.1		—			0.2			5.7			6.1
Loss on early extinguishment/modification of debt (d)	—		—			—		17.6			—			—			17.6
Foreign exchange loss (gain) on financing activities, net (e)	0.6		(1.9		)	0.1		—			0.1			16.4			15.3
Other	—		0.5			0.1		—			—			—			0.6
Total Adjusted EBITDA	$	46.9	$	39.5		$	35.8	$	8.6		$	46.5		$	(9.1	)	$	168.2
Three months ended March 31, 2012
Income (loss) before taxes	$	16.0	$	22.7		$	18.5	$	53.6		$	28.6		$	(19.1	)	$	120.3
Interest expense, net	1.0		5.2			2.2		1.9			4.6			5.6			20.5
Depreciation and amortization	10.7		7.9			15.1		17.3			12.8			2.0			65.8
Restructuring and other severance costs (a)	11.3		0.8			2.0		—			—			0.1			14.2
Systems/organization establishment expenses (b)	—		—			0.1		1.5			—			—			1.6
Loss on early extinguishment/modification of debt (d)	2.2		3.0			0.9		—			0.7			2.9			9.7
Foreign exchange loss (gain) on financing activities, net	3.2		—			—		—			(0.5		)	(1.7		)	1.0
Other (c)	—		0.1			—		1.3			0.1			0.3			1.8
Total Adjusted EBITDA	$	44.4	$	39.7		$	38.8	$	75.6		$	46.3		$	(9.9	)	$	234.9

(a) See Note 13, “Restructuring and Other Severance Costs,” for further details.

(b) Primarily represents costs incurred in conjunction with the integration of businesses acquired.

(c) Primarily represents professional fees incurred in connection with exploring strategic options.

(d) In 2013, this represents the write-off of deferred financing costs of $17.6 million in connection with the prepayment of the Titanium Dioxide Pigments facility agreement. In 2012, this represents redemption premiums of $6.7 million and the write-off of deferred financing costs of $3.0 million in connection with the redemption of the 2014 Notes.

(e) Primarily represents the foreign exchange loss in connection with intercompany Euro-denominated loans put in place to fund the prepayment of the outstanding borrowings under the Titanium Dioxide Pigments facility agreement.